1,529 results on '"Rolf A"'
Search Results
2. Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia
3. Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determine myeloma CAR-T outcomes
4. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
5. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
6. Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis
7. Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
8. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
9. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
10. Transfusion-related acute lung injury: incidence and risk factors.
11. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor
12. Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism
13. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
14. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells
15. Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
16. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
17. High Metabolic Tumor Volume Is Associated with Higher Toxicity and Decreased Efficacy of BCMA CAR-T Cell Therapy in Multiple Myeloma
18. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
19. Prothrombin forced into an awkward position
20. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase
21. BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Different Clinical Behavior and Relevance of Prognostic Features in Typical ALL and in CML-like Disease
22. CO-1: A Novel Bifunctional CD47 Antibody for the Treatment of Hematologic Malignancies
23. Trial in Progress: An Open-Label, Multi-Center, First in Human, Phase 1/2a Trial to Evaluate the Safety and Preliminary Efficacy of Autologous Tolerogenic Dendritic Cells Ex Vivo Loaded with Recombinant Factor VIII (FVIII) in Adults with Congenital Hemophilia a (HA) with Neutralizing Antibodies to FVIII and Having Failed Immune Tolerance Induction (ITI)
24. High Metabolic Tumor Volume Is Associated with Higher Toxicity and Decreased Efficacy of BCMA CAR-T Cell Therapy in Multiple Myeloma
25. The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas
26. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
27. Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis
28. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
29. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
30. Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
31. Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids
32. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
33. Trial in Progress: An Open-Label, Multi-Center, First in Human, Phase 1/2a Trial to Evaluate the Safety and Preliminary Efficacy of Autologous Tolerogenic Dendritic Cells Ex Vivo Loaded with Recombinant Factor VIII (FVIII) in Adults with Congenital Hemophilia a (HA) with Neutralizing Antibodies to FVIII and Having Failed Immune Tolerance Induction (ITI)
34. BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Different Clinical Behavior and Relevance of Prognostic Features in Typical ALL and in CML-like Disease
35. Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study
36. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling
37. The significance of autoantibodies against β2-glycoprotein I
38. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients
39. Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis
40. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
41. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
42. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset
43. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
44. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury
45. β2-Glycoprotein I: a novel component of innate immunity
46. The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells
47. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling
48. SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70
49. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome
50. High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.